Home Healthcare Market Size, Share & Trends Analysis Report and Segment Forecast, 2026| Grand View Research, Inc “The global home healthcare market size was valued at USD 305.78 billion in 2018 and is expected to register a CAGR of 7.8% over the forecast period.” The global Home Healthcare Market size is anticipated to reach USD 557.57 billion by 2026 registering a CAGR of 7.8%, according to a new report by Grand View Research, Inc. This growth can be attributed to improved patient outcome, cost-efficiency, and patient convenience provided by home healthcare. In addition, rising cases of diseases, such as dementia, Alzheimer’s, and orthopedic conditions, are expected to fuel market growth. For instance, according to the WHO, nearly 50 million individuals worldwide were suffering from dementia in 2017 and the number is anticipated to reach nearly 82 million by 2030. According to an article by United Nations, the number of individuals in age group of 80 years and above are anticipated to increase from nearly 137 million in 2017 to approximately 425 million in 2050. Thus, growing geriatric population base, which is highly susceptible to chronic conditions, such as diabetes and CVDs, and prefer in-home care, is anticipated to fuel the market growth. Furthermore, geriatric population. The establishment and maintenance of hospitals and other healthcare settings is capital-intensive. Hence, several healthcare solution providers are entering into home healthcare market through M&A to reudce the costs and leverage the expertise of the merged or acquired firm. For instance, Allegheny Health Network, a Pittsburgbased organization, entered into the market by acquiring four companies, which had expertise in four different home health services, such as infusion therapy, hospice, medical equipment, and home nursing. Follow Us: To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/home-healthcare-industry Further key findings from the study suggest: Services led the component segment in 2018. Rehabilitation services accounted for more than 50.0% of the overall home healthcare market in 2018 Therapeutic equipment segment led the market in 2018 and is projected to expand further Growing prevalence of respiratory and urological disorders and advent of advanced products suitable for home healthcare like portable dialysis machines will drive the segment North America was the dominant regional market in 2018 due to advanced medical infrastructure, favorable reimbursement framework, and comparatively higher healthcare expenditure in the region Some of the key companies in the market are Almost Family, Inc.; B. Braun Melsungen AG; Abbott Laboratories; Sunrise Medical; 3M Healthcare; Baxter International, Inc.; Medtronic PLC; Cardinal Health, Inc.; F. Hoffmann-La Roche AG; and Air Liquide Grand View Research has segmented the global home healthcare market on the basis of component and region: Home Healthcare Component Outlook (Revenue, USD Million, 2015 - 2026) Equipment o Therapeutic o Diagnostic o Mobility assist Services Follow Us: o Rehabilitation Services o Unskilled Home Care o Respiratory Therapy Services o Infusion Therapy Services o Telemetry Home Healthcare Regional Outlook (Revenue, USD Million, 2015 - 2026) North America o U.S. o Canada Europe o Germany o U.K. o France o Italy o Spain o Russia o Netherlands Asia Pacific o China o Japan o India o Thailand o Korea o Philippines o Malaysia o Singapore o Australia Latin America Follow Us: o Brazil o Mexico o Argentina Middle East and Africa (MEA) Follow Us: o South Africa o Saudi Arabia o UAE o Oman o Egypt Table of Content of Home Healthcare Market Chapter 1 Report Scope 1.1 Market Segmentation 1.2 Segment Market Scope 1.3 Regional Scope Chapter 2 Market Definition 2.1 Equipment 2.1.1 Therapeutic 2.1.1.1 Home respiratory therapy 2.1.1.2 Insulin delivery 2.1.1.3 Home IV (intravenous) pumps 2.1.1.4 Home dialysis equipment 2.1.2 Diagnostics Home Healthcare Equipment 2.1.2.1 Diabetic care unit 2.1.2.2 BP monitors 2.1.2.3 Multi parameter diagnostic monitors 2.1.2.4 Home pregnancy and fertility kits 2.1.2.5 Apnea and sleep monitors 2.1.2.6 Holter monitors 2.1.2.7 Heart rate meters(include pacemakers) 2.1.3 Mobility Assist Equipment 2.1.3.1 Wheelchair 2.1.3.2 Home medical furniture 2.1.3.3 Walking assist devices 2.2 Service 2.2.1 Rehabilitation Services 2.2.2 Unskilled Home Care 2.2.3 Respiratory Therapy Services 2.2.4 Infusion Therapy Services 2.2.5 Telemetry Follow Us: 2.3 Estimates and Forecast Timeline Chapter 3 Methodology 3.1 Research Methodology 3.1.1 Information Procurement 3.1.2 Purchased Database 3.1.3 GVR’S Internal Database 3.1.4 Secondary Sources 3.1.5 Primary Research 3.2 Information or Data Analysis 3.2.1 Data Analysis Models 3.3 Market Formulation & Validation 3.4 Region Wise Market Calculation 3.4.1 Region Wise Market: Base Estimates 3.4.2 Global Market: CAGR Calculation 3.5 Region Based Segment Share Calculation 3.6 Model Details 3.6.1 Commodity Flow Analysis 3.6.2 Volume Price Analysis 3.7 List of Secondary Sources 3.8 List of Abbreviations Chapter 4 Objectives 4.1 Objective - 1 4.2 Objective - 2 4.3 Objective - 3 4.4 Objective - 4 Chapter 5 Executive Summary Chapter 6 Industry Outlook 6.1 Market Lineage outlook 6.1.1 Parent Market Outlook 6.1.2 Related/Ancillary Market Outlook 6.2 User perspective analysis Follow Us: 6.2.1 Consumer Behavior Analysis 6.3 Business Segment Trends 6.3.1 Product Business Analysis 6.3.2 Regional Business Analysis 6.4 Market Dynamics 6.4.1 Market Driver Analysis 6.4.1.1 Home healthcare as a cost-effective alternative 6.4.1.2 Growing number of home health and personal care aides 6.4.1.3 Growing geriatric population 6.4.1.4 Hospital solution providers penetrating the home healthcare market 6.4.1.5 Growing prevalence of target diseases, especially Alzheimer’s and other dementias 6.4.2 Market Restraint Analysis 6.4.2.1 Lower remunerations 6.5 Industry Challenges 6.5.1 Complicated reimbursement framework and reimbursement cuts 6.6 Penetration & Growth Prospect Mapping 6.7 Business Environment Analysis tools 6.7.1 SWOT Analysis, By PEST 6.7.2 PORTER’S Five Forces Analysis 6.7.3 Industry Analysis - Ansoff Matrix Chapter 7 Regulatory & Political Forces 7.1 North America 7.1.1 U.S. 7.1.2 CANADA 7.2 Europe 7.3 Asia Chapter 8 Product Analysis 8.1 Home Healthcare Market: Component Movement Analysis 8.2 Equipment 8.2.1 Equipment Market, 2015 - 2026 (USD Million) 8.2.2 Therapeutic Follow Us: 8.2.2.1 Therapeutic market, 2015 - 2026 (USD Million) 8.2.2.2 Home respiratory therapy 8.2.2.2.1 Home respiratory therapy market, 2015 - 2026 (USD Million) 8.2.2.3 Insulin delivery 8.2.2.3.1 Insulin delivery market, 2015 - 2026 (USD Million) 8.2.2.4 Home intravenous Pumps 8.2.2.4.1 Home IV pumps market, 2015 - 2026 (USD Million) 8.2.2.5 Home dialysis equipment 8.2.2.5.1 Home dialysis equipment market, 2015 - 2026 (USD Million) 8.2.2.6 Other therapeutic equipment 8.2.2.6.1 Other therapeutic equipment market, 2015 - 2026 (USD Million) 8.2.3 Diagnostics 8.2.3.1 Diagnostics market, 2015 - 2026 (USD Million) 8.2.3.2 Diabetic care unit 8.2.3.2.1 Diabetic Care Unit market, 2015 - 2026 (USD Million) 8.2.3.3 BP monitors 8.2.3.3.1 BP monitors market, 2015 - 2026 (USD Million) 8.2.3.4 Multi parameter diagnostic monitors 8.2.3.4.1 Multi parameter diagnostic monitors market, 2015 - 2026 (USD Million) 8.2.3.5 Home pregnancy and fertility kits 8.2.3.5.1 Home pregnancy and fertility kits market, 2015 - 2026 (USD Million) 8.2.3.6 Other self-monitoring equipment 8.2.3.6.1 Other self-monitoring equipment market, 2015 - 2026 (USD Million) 8.2.3.7 Apnea and sleep monitors 8.2.3.7.1 Apnea and sleep monitors market, 2015 - 2026 (USD Million) 8.2.3.8 Holter monitors 8.2.3.8.1 Holter monitors market, 2015 - 2026 (USD Million) 8.2.3.9 heart rate monitor 8.2.3.9.1 heart rate monitor market, 2015 - 2026 (USD Million) 8.2.3.10 Others EQUIPMENT 8.2.3.10.1 Other equipment market, 2015 - 2026 (USD Million) Follow Us: 8.2.4 Mobility Assist Equipment 8.2.4.1 Mobility assist equipment market, 2015 - 2026 (USD Million) 8.2.4.2 Wheelchair 8.2.4.2.1 Wheelchair market, 2015 - 2026 (USD Million) 8.2.4.3 Home medical furniture 8.2.4.3.1 Home medical furniture market, 2015 - 2026 (USD Million) 8.2.4.4 Walking assist devices 8.2.4.4.1 Walking assist devices market, 2015 - 2026 (USD Million) 8.3 Services 8.3.1 Services Market, 2015 - 2026 (USD Million) 8.3.2 Rehabilitation Services 8.3.2.1 Rehabilitation services market, 2015 - 2026 (USD Million) 8.3.3 Unskilled Homecare 8.3.3.1 Unskilled homecare market, 2015 - 2026 (USD Million) 8.3.4 Respiratory Therapy Services 8.3.4.1 Respiratory therapy services market, 2015 - 2026 (USD Million) 8.3.5 Infusion Therapy Services 8.3.5.1 Infusion therapy services market, 2015 - 2026 (USD Million) 8.3.6 Telemetry 8.3.6.1 Telemetry market, 2015 - 2026 (USD Million) Chapter 9 Regional Outlook 9.1 Home Healthcare Market Share by Region, 2018 & 2026 9.2 Regional Leading Players, 2018 9.3 Regional SWOT Analysis, by Factor (Political & Legal, Economic And Technological) 9.3.1 NORTH AMERICA 9.3.2 EUROPE 9.3.3 ASIA PACIFIC 9.3.4 LATIN AMERICA 9.3.5 MEA 9.4 North America 9.4.1 North America Home Healthcare Market, 2015 - 2026 (USD MILLION) Follow Us: 9.4.2 U.S. 9.4.2.1 U.S. home healthcare market, 2015 - 2026 (USD Million) 9.4.3 CANADA 9.4.3.1 Canada home healthcare market, 2015 - 2026 (USD Million) 9.5 Europe 9.5.1 Europe Home Healthcare Market, 2015 - 2026 (USD MILLION) 9.5.2 UK 9.5.2.1 UK home healthcare market, 2015 - 2026 (USD Million) 9.5.3 Germany 9.5.3.1 Germany home healthcare market, 2015 - 2026 (USD Million) 9.5.4 Italy 9.5.4.1 Italy home healthcare market, 2015 - 2026 (USD Million) 9.5.5 Spain 9.5.5.1 Spain home healthcare market, 2015 - 2026 (USD Million) 9.5.6 Sweden 9.5.6.1 Sweden home healthcare market, 2015 - 2026 (USD Million) 9.5.7 France 9.5.7.1 France home healthcare market, 2015 - 2026 (USD Million) 9.5.8 Russia 9.5.8.1 Russia home healthcare market, 2015 - 2026 (USD Million) 9.5.9 Netherlands 9.5.9.1 Netherlands home healthcare market, 2015 - 2026 (USD Million) 9.6 Asia Pacific 9.6.1 Asia Pacific Home Healthcare Market, 2015 - 2026 (USD MILLION) 9.6.2 Japan 9.6.2.1 Japan home healthcare market, 2015 - 2026 (USD Million) 9.6.3 China 9.6.3.1 China home healthcare market, 2015 - 2026 (USD Million) 9.6.4 India 9.6.4.1 India home healthcare market, 2015 - 2026 (USD Million) 9.6.5 Australia Follow Us: 9.6.5.1 Australia home healthcare market, 2015 - 2026 (USD Million) 9.6.6 Singapore 9.6.6.1 Singapore home healthcare market, 2015 - 2026 (USD Million) 9.6.7 Malaysia 9.6.7.1 Malaysia home healthcare market, 2015 - 2026 (USD Million) 9.6.8 Thailand 9.6.8.1 Thailand home healthcare market, 2015 - 2026 (USD Million) 9.6.9 Philippines 9.6.9.1 Philippines home healthcare market, 2015 - 2026 (USD Million) 9.6.10 Korea 9.6.10.1 Korea home healthcare market, 2015 - 2026 (USD Million) 9.7 Latin America 9.7.1 Latin America Home Healthcare Market, 2015 - 2026 (USD MILLION) 9.7.2 Brazil 9.7.2.1 Brazil home healthcare market, 2015 - 2026 (USD Million) 9.7.3 Mexico 9.7.3.1 Mexico home healthcare market, 2015 - 2026 (USD Million) 9.7.4 Argentina 9.7.4.1 Argentina home healthcare market, 2015 - 2026 (USD Million) 9.8 MEA 9.8.1 MEA Home Healthcare Market, 2015 - 2026 (USD MILLION) 9.8.2 South Africa 9.8.2.1 South Africa home healthcare market, 2015 - 2026 (USD Million) 9.8.3 Saudi Arabia 9.8.3.1 Saudi Arabia home healthcare market, 2015 - 2026 (USD Million) 9.8.4 Oman 9.8.4.1 Oman home healthcare market, 2015 - 2026 (USD Million) 9.8.5 UAE 9.8.5.1 UAE home healthcare market, 2015 - 2026 (USD Million) 9.8.6 Egypt 9.8.6.1 Egypt home healthcare market, 2015 - 2026 (USD Million) Follow Us: Chapter 10 Competitive & Vendor Landscape 10.1 Participant Categorization 10.1.1 Innovators 10.1.2 Market leaders 10.1.2.1 Home healthcare equipment market 10.1.2.2 Home healthcare services market 10.1.3 Strategy Mapping 10.1.3.1 Launch of new products 10.1.3.2 Acquisition 10.1.3.3 Expansion 10.1.3.4 Agreements, collaborations, partnerships 10.1.3.5 Others (realignment, divestment, market penetration) 10.2 Strategic Framework Chapter 11 Company Profiles 11.1 ALMOST FAMILY, INC. 11.1.1 Company overview 11.1.2 Financial performance 11.1.3 Product benchmarking 11.1.4 Strategic initiatives 11.2 B. BRAUN MELSUNGEN AG 11.2.1 Company overview 11.2.2 Financial performance 11.2.3 Product benchmarking 11.2.4 Strategic initiatives 11.3 ABBOTT 11.3.1 Company overview 11.3.2 Financial performance 11.3.3 Product benchmarking 11.3.4 Strategic initiatives 11.4 SUNRISE MEDICAL 11.4.1 Company overview Follow Us: 11.4.2 Financial Performance 11.4.3 Product benchmarking 11.4.4 Strategic initiatives 11.5 3M HEALTHCARE 11.5.1 Company overview 11.5.2 Financial performance 11.11.5.3 Product benchmarking 11.5.4 Strategic initiatives 11.6 BAXTER INTERNATIONAL INC. 11.6.1 Company overview 11.6.2 Financial performance 11.6.3 Product benchmarking 11.6.4 Strategic initiatives 11.7 MEDTRONIC PLC 11.7.1 Company overview 11.7.2 Financial performance 11.7.3 Product benchmarking 11.7.4 Strategic initiatives 11.8 CARDINAL HEALTH INC. 11.8.1 Company overview 11.8.2 Financial performance 11.8.3 Product benchmarking 11.8.4 Strategic initiatives 11.9 F. HOFFMANN-LA ROCHE AG 11.9.1 Company overview 11.9.2 Financial performance 11.9.3 Product benchmarking 11.9.4 Strategic initiatives 11.10 AIR LIQUIDE 11.10.1 Company overview 11.10.2 Financial performance Follow Us: 11.10.3 Product benchmarking 11.10.4 Strategic initiatives. 11.11 AMEDISYS, INC. 11.11.1 Company overview 11.11.2 Financial performance 11.11.3 Product benchmarking 11.11.4 Strategic initiatives 11.12 NXSTAGE MEDICAL, INC. (FRESENIUS MEDICAL CARE) 11.12.1 Company overview 11.12.2 Financial performance 11.12.3 Product benchmarking 11.12.4 Strategic initiatives 11.13 ARKRAY, INC. 11.13.1 Company overview 11.13.2 Financial performance 11.13.3 Product benchmarking 11.13.4 Strategic Initiatives 11.14 BECTON, DICKINSON AND COMPANY 11.14.1 Company overview 11.14.2 Financial performance 11.14.3 Product benchmarking 11.14.4 Strategic initiatives 11.15 KINDRED HEALTHCARE, INC. 11.15.1 Company overview 11.15.2 Financial performance 11.15.3 Product benchmarking 11.15.4 Strategic initiatives 11.16 NATIONAL HEALTHCARE CORPORATION 11.16.1 Company overview 11.16.2 Financial performance 11.16.3 Product benchmarking Follow Us: 11.16.4 Strategic initiatives 11.17 OMRON HEALTHCARE, INC. 11.17.1 Company overview 11.17.2 Financial performance 11.17.3 Product benchmarking 11.17.4 Strategic initiatives 11.18 DRIVE DEVILBISS HEALTHCARE 11.18.1 Company overview 11.18.2 Product benchmarking 11.18.3 Strategic initiatives 11.19 CHUBB FIRE & SECURITY PTY LTD 11.19.1 Company overview 11.19.2 Financial performance 11.19.3 Product benchmarking 11.19.4 Strategic initiatives 11.20 GE HEALTHCARE 11.20.1 Company overview 11.20.2 Financial performance 11.20.3 Product benchmarking 11.20.4 Strategic initiatives 11.21 MEDLINE INDUSTRIES, INC. 11.21.1 Company overview 11.21.2 Financial performance 11.21.3 Product benchmarking 11.21.4 Strategic initiatives 11.22 KONINKLIJKE PHILIPS N.V. 11.22.1 Company overview 11.22.2 Financial performance 11.22.3 Product benchmarking 11.22.4 Strategic initiatives 11.23 GF HEALTH PRODUCTS, INC. Follow Us: 11.23.1 Company overview 11.23.2 Financial performance 11.23.3 Product benchmarking 11.23.4 Strategic initiatives 11.24 HILL-ROM, INC. 11.24.1 Company overview 11.24.2 Financial performance 11.24.3 Product benchmarking 11.24.4 Strategic initiatives 11.25 GENTIVA HEALTH SERVICES, INC. 11.25.1 Company overview 11.25.2 Financial performance 11.25.3 Product benchmarking 11.25.4 Strategic initiatives 11.26 JOHNSON & JOHNSON SERVICES, INC. 11.26.1 Company overview 11.26.2 Financial performance 11.26.3 Product benchmarking 11.26.4 Strategic initiatives 11.27 LINDE HEALTHCARE 11.27.1 Company overview 11.27.2 Financial performance 11.7.3 Product benchmarking 11.27.4 Strategic initiatives 11.28 ACELITY 11.28.1 Company overview 11.28.2 Financial performance 11.28.3 Product benchmarking 11.28.4 Strategic initiatives 11.29 VYGON 11.29.1 Company overview Follow Us: 11.29.2 Financial performance 11.29.3 Product benchmarking 11.30 TELEFLEX, INC. 11.30.1 Company overview 11.30.2 Financial performance 11.30.3 Product benchmarking 11.31 MOOG INC. 11.31.1 Company overview 11.31.2 Financial performance 11.31.3 Product benchmarking 11.32 INTERSURGICAL LTD. 11.32.1 Company overview 11.32.2 Product benchmarking 11.33 FRESENIUS KABI AG. 11.33.1 Company overview 11.33.2 Financial performance 11.33.3 Product benchmarking 11.33.4 Strategic initiatives 11.34 BAYER HEALTHCARE 11.34.1 Company overview 11.34.2 Financial performance 11.34.3 Product benchmarking 11.34.4 Strategic initiatives 11.35 GF HEALTH PRODUCTS, INC. 11.35.1 Company overview 11.35.2 Financial performance 11.35.3 Product benchmarking 11.35.4 Strategic initiatives 11.36 MEDCO HOME HEALTHCARE, INC. 11.36.1 Company overview 11.36.2 Financial performance Follow Us: 11.36.3 Product benchmarking 11.37 ARCADIA 11.37.1 Company overview 11.37.2 Financial performance 11.37.3 Product benchmarking 11.37.4 Strategic initiatives Chapter 12 Recommendations About Us: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Follow Us: Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: [email protected] For More Information: https://www.grandviewresearch.com Blog: https://healthcareforecastreport.blogspot.com/ Follow Us:
The global home healthcare market size is anticipated to reach USD 557.57 billion by 2026
© Copyright 2024 Paperzz